News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024